全科牙医对颌骨药物性骨坏死的认知、态度及处理
Knowledge, Attitude, and Management of General Dentist toward Medication-related Osteonecrosis of the Jaws.
作者信息
Alqhtani Nasser R, Almalki Abdulrahman K, Zuhair Faisal A, Alenazi Adel A, Nabhan Abdullah Bin, Alqahtani Mana
机构信息
Department of Oral and Maxillofacial Surgery and Diagnostic Science, College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Intern, College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi-Arabia.
出版信息
J Pharm Bioallied Sci. 2020 Aug;12(Suppl 1):S151-S154. doi: 10.4103/jpbs.JPBS_47_20. Epub 2020 Aug 28.
Abstract
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is an intense negative drug response causing increasing bone destruction in the maxillofacial area of patients.
AIMS AND OBJECTIVES
To evaluate the knowledge and attitude of dental practitioner regarding risk factors of MRONJ in Saudi Arabia.
MATERIALS AND METHODS
A cross-sectional, questionnaire survey was carried out in King Khalid Hospital, Al-Kharj among dental practioners.
RESULTS
Approximately 60% of the practioners had a poor knowledge and there was a weak positive correlation with work experience.
CONCLUSION
Poor knowledge regarding the MRONJ invites a continuing dental education specially to focus on general practioners.
摘要
背景
药物相关性颌骨坏死（MRONJ）是一种严重的负面药物反应，会导致患者颌面部骨破坏不断增加。
目的
评估沙特阿拉伯牙科医生对MRONJ危险因素的了解和态度。
材料与方法
在哈吉尔的哈立德国王医院对牙科医生进行了一项横断面问卷调查。
结果
约60%的医生了解不足，且与工作经验呈弱正相关。
结论
对MRONJ的了解不足促使开展持续牙科教育，尤其应关注全科医生。
相似文献
1
Knowledge, Attitude, and Management of General Dentist toward Medication-related Osteonecrosis of the Jaws.全科牙医对颌骨药物性骨坏死的认知、态度及处理
J Pharm Bioallied Sci. 2020 Aug;12(Suppl 1):S151-S154. doi: 10.4103/jpbs.JPBS_47_20. Epub 2020 Aug 28.
2
Dentists' knowledge about medication-related osteonecrosis of the jaw and its management.牙医对药物性颌骨坏死及其治疗的了解。
Heliyon. 2020 Jul 27;6(7):e04321. doi: 10.1016/j.heliyon.2020.e04321. eCollection 2020 Jul.
3
Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society.口腔颌面部药物相关性骨坏死知识和意识的横断面调查：在牙科协会样本中的调查。
J Craniomaxillofac Surg. 2019 Jun;47(6):926-931. doi: 10.1016/j.jcms.2019.02.006. Epub 2019 Mar 19.
4
Dental students' knowledge of medication-related osteonecrosis of the jaw.牙科学生对药物相关性颌骨坏死的认识。
Eur J Dent. 2017 Oct-Dec;11(4):461-468. doi: 10.4103/ejd.ejd_27_17.
5
Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.药物相关性颌骨坏死：临床与实践指南
J Int Soc Prev Community Dent. 2016 Mar-Apr;6(2):97-104. doi: 10.4103/2231-0762.178742.
6
Knowledge of Dental Students and Practitioners About Medication-Related Osteonecrosis of the Jaw in the Central Region of Saudi Arabia.沙特阿拉伯中部地区牙科学生和从业者对颌骨药物性骨坏死的了解情况。
Cureus. 2024 Jan 12;16(1):e52165. doi: 10.7759/cureus.52165. eCollection 2024 Jan.
7
Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).牙种植体作为颌骨药物相关性骨坏死（MRONJ）患者的危险因素。
Br J Oral Maxillofac Surg. 2020 Sep;58(7):771-776. doi: 10.1016/j.bjoms.2020.03.022. Epub 2020 Jul 3.
8
Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain).药物相关性颌骨坏死：西班牙阿斯图里亚斯公国牙医知识、态度和实践调查。
J Stomatol Oral Maxillofac Surg. 2018 Nov;119(5):395-400. doi: 10.1016/j.jormas.2018.04.008. Epub 2018 Apr 21.
9
Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws.韩国牙医对颌骨双膦酸盐相关骨坏死认知情况的调查
J Investig Clin Dent. 2010 Nov;1(2):90-5. doi: 10.1111/j.2041-1626.2010.00024.x.
10
Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy.对有发生颌骨药物相关性骨坏死（MRONJ）风险患者的认知——一项一级预防策略。
Saudi Pharm J. 2020 Jun;28(6):771-778. doi: 10.1016/j.jsps.2020.05.004. Epub 2020 May 15.
引用本文的文献
1
Addressing Osteonecrosis: A preventable catastrophe - A multi-center study.应对骨坏死：一场可预防的灾难——一项多中心研究。
Pak J Med Sci. 2023 Jan-Feb;39(1):262-267. doi: 10.12669/pjms.39.1.5985.
2
Teledentistry as a Supportive Tool for Dentists in Diagnosing MRONJ in Northern Cyprus.远程牙科作为北塞浦路斯牙医诊断 MRONJ 的辅助工具。
Biomed Res Int. 2021 Dec 29;2021:5657152. doi: 10.1155/2021/5657152. eCollection 2021.
本文引用的文献
1
Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society.口腔颌面部药物相关性骨坏死知识和意识的横断面调查：在牙科协会样本中的调查。
J Craniomaxillofac Surg. 2019 Jun;47(6):926-931. doi: 10.1016/j.jcms.2019.02.006. Epub 2019 Mar 19.
2
Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England.患者对药物相关性颌骨坏死 (MRONJ)的认知和态度：英格兰的一项定性研究。
BMJ Open. 2019 Mar 3;9(3):e024376. doi: 10.1136/bmjopen-2018-024376.
3
Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain).药物相关性颌骨坏死：西班牙阿斯图里亚斯公国牙医知识、态度和实践调查。
J Stomatol Oral Maxillofac Surg. 2018 Nov;119(5):395-400. doi: 10.1016/j.jormas.2018.04.008. Epub 2018 Apr 21.
4
Dental students' knowledge of medication-related osteonecrosis of the jaw.牙科学生对药物相关性颌骨坏死的认识。
Eur J Dent. 2017 Oct-Dec;11(4):461-468. doi: 10.4103/ejd.ejd_27_17.
5
Knowledge of bisphosphonate-related osteonecrosis of the Jawsamong Mexican dentists.墨西哥牙医对双膦酸盐相关颌骨坏死的了解情况。
Med Oral Patol Oral Cir Bucal. 2017 Jan 1;22(1):e84-e87. doi: 10.4317/medoral.21433.
6
Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.安大略省牙医在治疗接受双膦酸盐治疗的患者时的知识、实践和观点。
J Oral Maxillofac Surg. 2015 Jun;73(6):1095-105. doi: 10.1016/j.joms.2014.12.040. Epub 2015 Jan 12.
7
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.
8
Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors.唑来膦酸治疗多发性骨髓瘤或实体瘤骨转移患者 24 个月以上的治疗模式、疗效和安全性的前瞻性观察研究。
Support Care Cancer. 2013 Dec;21(12):3483-90. doi: 10.1007/s00520-013-1934-0. Epub 2013 Aug 18.
9
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.利塞膦酸钠治疗成骨不全症儿童：一项随机、双盲、安慰剂对照试验。
Lancet. 2013 Oct 26;382(9902):1424-32. doi: 10.1016/S0140-6736(13)61091-0. Epub 2013 Aug 6.
10
Pathogenesis and management of Paget's disease of bone.骨佩吉特病的发病机制与管理
Lancet. 2008 Jul 12;372(9633):155-163. doi: 10.1016/S0140-6736(08)61035-1.
Zotero 插件